Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 20, 2003, Pages 11741-11746

  Prokai, Laszlo ^a   Prokai Tatrai, Katalin ^b   Perjesi, Pal ^a   Zharikova, Alevtina D ^a   Perez, Evelyn J ^c   Liu, Ran ^c   Simpkins, James W ^c  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Hydroxyl radical; Ischemia; Prodrug

Indexed keywords

ANTIOXIDANT; CATECHOL DERIVATIVE; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE DERIVATIVE; GLUTAMIC ACID; HYDROXYL RADICAL; PHENOL DERIVATIVE; PRODRUG; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SCAVENGER; STEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME MECHANISM; FENTON REACTION; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REDUCTION; REPERFUSION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIOXIDANTS; BRAIN ISCHEMIA; CHROMATOGRAPHY, LIQUID; ESTROGENS; FEMALE; FREE RADICAL SCAVENGERS; HYDROQUINONES; HYDROXYL RADICAL; MASS SPECTROMETRY; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0141593536     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.2032621100     Document Type: Article

References (41)

1. Blanchet, P. J., Fang, J., Hyland, K., Arnold, L. A., Mouradian, M. M. & Chase, T. N. (1999) Neurology 53, 91-95.
2. Lee, S. B. & McEwen, B. S. (2001) Annu. Rev. Pharmacol. Toxicol. 41, 569-591.
3. Green, P. S. & Simpkins, J. W. (2000) Int. J. Dev. Neurosci. 18, 357-358.
4. Behl, C. (2002) Nat. Rev. Neurosci. 3, 433-442.
5. Hall, J. M., Couse, J. F. & Korach, K. F. (2001) J. Biol. Chem. 276, 36869-36872.
6. Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., Bottner, M. & Rosewell, K. L. (2001) Brain Res. Rev. 37, 313-319.
7. Lonard, D. M. & Smith, C. L. (2002) Steroids 67, 15-24.
8. Garcia-Segura, L. M., Cardona-Gomez, P., Naftolin, F. & Chowen, J. A. (1998) Neuroreport 9, 595-597.
9. Wong, M. & Moss, R. L. (1992) J. Neurosci. 12, 3217-3225.
10. Weaver, C. E., Park-Chung, M., Gibbs, T. T. & Farb, D. (1997) Brain Res. 761, 338-341.
11. Behl, C., Skutella, T., Lezoulac'h, F., Post, A., Widmann, M., Newton, C. & Hoelsboer, F. (1997) Mol. Pharmacol. 51, 535-541.
12. Green, P. S., Bishop, J. & Simpkins, J. W. (1997) J. Neurosci. 17, 511-515
13. Moosmann, B. & Behl, C. (1999) Proc. Natl. Acad. Sci. USA 96, 8867-8872.
14. Vedder, H., Anthes, N., Stumm, G., Wurz, C., Behl, C. & Krieg, J. C. (1999) J. Neurochem. 72, 2531-2538.
15. Halliwell, B. (2001) Drugs Aging 18, 685-716.
16. Cuzzocrea, S., Riley, D. P., Caputi, A. P. & Salvemini, D. (2001) Pharmacol. Rev. 53, 135-159.
17. Bush, A. J. (2000) Curr. Opin. Chem. Biol. 4, 184-191.
18. Bishop, G. M. & Robinson, S. R. (2001) Brain Res. 90, 175-187.
19. Halliwell, B. (1992) J. Neurochem. 56, 1609-1623.
20. Walling, C. (1975) Acc. Chem. Res. 28, 125-131.
21. Culmsee, C., Vedder, H., Ravati, A., Junker, V., Otto, D., Ahlemeyer, B., Krieg, J. C. & Krieglstein, J. (1999) J. Cereb. Blood Flow Metab. 19, 1263-1269.
22. Wickelgren, I. (1997) Science 276, 675-678.
23. Solaja, B. A., Milic, D. R. & Gasic, M. J. (1996) Tetrahedron Lett. 37, 3765-3768.
24. Prokai, L., Oon, S. M., Prokai-Tatrai, K., Abboud, K. A. & Simpkins, J. W. (2001) J. Med. Chem. 44, 110-114.
25. Lowry, O. H., Rosenbrough, N. J., Farr, A. L. & Randall, R. J. (1951) J. Biol. Chem. 193, 265-275.
26. Prokai, L., Kim, H. S., Zharikova, A. D., Roboz, J., Ma, L., Deng, L. & Simonsick, W. J., Jr. (1998) J. Chromatogr. A. 800, 59-68.
27. Nutter, L. N. Wu, Y.-Y., Ngo, E. O., Sierra, E. E., Gutierrez, P. L. & Abdul-Hajj, Y. J. (1994) Chem. Res. Toxicol. 7, 23-28.
28. Green, P. S., Perez, E. J., Calloway, T. & Simpkins, J. W. (2000) J. Neurocytol. 29, 419-423.
29. Lee, A. J., Kosh, J. W., Conney, A. H. & Zhu, B. T. (2001) J. Pharmacol. Exp. Ther. 298, 420-432.
30. Ohe, T., Hirobe, M. & Mashino, T. (2002) Drug Metab. Dispos. 28, 110-112.
31. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johanson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) Proc. Natl. Acad. Sci. USA 94, 10937-10942.
32. Ma, Y. C. & Kim, H. Y, (1997) J. Am. Soc. Mass Spectrom. 8, 1010-1020.
33. Nielsen, J. & Brinton, R. D. (2002) Endocrinology 143, 205-212.
34. Forman, L. G., Liu, P., Nagele, R. G., Yin, K. & Wong, P. Y. (1998) Neurochem. Res. 23, 141-148.
35. Peters, O., Back, T., Lindauer, U., Busch, C., Megow, D., Dreier, J. & Dirnagl, U. (1998) Cereb. Blood Flow Metab. 18, 196-205.
36. Mason, R. B., Pluta, R. M., Walbridge, S., Wink, D. A., Oldfield, E. H. & Boock, R. J. (2000) J. Neurosurg. 93, 99-107.
37. Yang, S. H., Shi, J., Day, A. L. & Simpkins, J. W. (2000) Stroke 31, 745-749.
38. Shi, J., Yang, S. H., He, Z., Lucas, T. H., Buckley, D. L., Blackband, S. J., King, M. A., Day, A. L. & Simpkins, J. W. (2001) Stroke 32, 987-992.
39. Liu, R., Yang, S. H., Perez, E., Yi, K. D., Wu, S. S., Eberst, K., Prokai, L., Prokai-Tatrai, K., Cai, Y. C., Covey, D. F., et al. (2002) Stroke 33, 2485-2491.
40. Stella, V. J., Charman, W. N. A. & Naringrekar, V. H. (1985) Drugs 29, 455-473.
41. Takata, J., Matsunaga, K. & Karube, Y. (2002) Toxicology 180, 183-193.